{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:13:41Z","timestamp":1793726021943,"version":"4.6.1"},"reference-count":63,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,1]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of the review<\/jats:title>\n            <jats:p>Emerging data suggest that regulatory T-cells (Treg) alterations play a major role in systemic vasculitis pathophysiology. We performed a systematic review of recent advances in the role of Treg and interleukin (IL)-10 in the pathogenesis and treatment of systemic vasculitis, including giant cell arteritis (GCA), Takayasu arteritis, Beh\u00e7et's disease, antineutrophil cytoplasm antibodies (ANCA) associated vasculitis (AAV), and cryoglobulinemia associated vasculitis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>Emerging data suggest that Treg deficiencies are disease-specific, affecting distinct pathways in distinct vasculitides. Decreased peripheral blood frequencies of Treg are described in all vasculitis when compared to healthy donors. Altered Treg functions are reported in GCA, Takayasu arteritis, AAV, and Beh\u00e7et's disease with different mechanisms proposed. Treatment with biologics, and sometimes other immunosuppressants, may restore Treg frequencies and\/or immune activity with significant differences in active disease or disease in remission in several systemic vasculitis. IL-10 is elevated in GCA, AAV, cryoglobulinemia associated vasculitis. In Beh\u00e7et's disease, IL-10 is decreased in peripheral blood and elevated in saliva. In Takayasu arteritis, IL-10 levels were essentially elevated in patients\u2019 vessel wall. Several new therapeutic approaches targeting Treg and Il-10 (low dose IL-2, CAR Treg\u2026) are developed to treat patients with systemic vasculitis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>Treg and IL-10 play a central role in the regulation of inflammation in vasculitis and new targeting approaches are emerging.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/bor.0000000000000915","type":"journal-article","created":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T18:00:30Z","timestamp":1670868030000},"page":"25-30","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":11,"title":["Regulatory T cells and systemic vasculitis"],"prefix":"10.1097","volume":"35","author":[{"given":"Adrien","family":"Mirouse","sequence":"first","affiliation":[{"name":"Sorbonne Universit\u00e9, APHP, Department of Internal Medicine and Clinical Immunology, Groupe Hospitalier Piti\u00e9-Salp\u00eatri\u00e8re France"},{"name":"Centre National de R\u00e9f\u00e9rences Maladies Autoimmunes et Syst\u00e9miques Rares, Centre National de R\u00e9f\u00e9rences Maladies Autoinflammatoires Rares et Amylose Inflammatoire, INSERM, UMR S 959, Immunology-Immunopathology-Immunotherapy, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrice","family":"Cacoub","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9, APHP, Department of Internal Medicine and Clinical Immunology, Groupe Hospitalier Piti\u00e9-Salp\u00eatri\u00e8re France"},{"name":"Centre National de R\u00e9f\u00e9rences Maladies Autoimmunes et Syst\u00e9miques Rares, Centre National de R\u00e9f\u00e9rences Maladies Autoinflammatoires Rares et Amylose Inflammatoire, INSERM, UMR S 959, Immunology-Immunopathology-Immunotherapy, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Saadoun","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9, APHP, Department of Internal Medicine and Clinical Immunology, Groupe Hospitalier Piti\u00e9-Salp\u00eatri\u00e8re France"},{"name":"Centre National de R\u00e9f\u00e9rences Maladies Autoimmunes et Syst\u00e9miques Rares, Centre National de R\u00e9f\u00e9rences Maladies Autoinflammatoires Rares et Amylose Inflammatoire, INSERM, UMR S 959, Immunology-Immunopathology-Immunotherapy, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,10,20]]},"reference":[{"key":"R1-20250526","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis Rheum"},{"key":"R2-20250526","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ni904","article-title":"Foxp3 programs the development and function of CD4+CD25+ regulatory T cells","volume":"4","author":"Fontenot","year":"2003","journal-title":"Nat Immunol"},{"key":"R3-20250526","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1146\/annurev.immunol.25.022106.141623","article-title":"Regulatory T cells: mechanisms of differentiation and function","volume":"30","author":"Josefowicz","year":"2012","journal-title":"Annu Rev Immunol"},{"key":"R4-20250526","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.immuni.2012.09.010","article-title":"T cell receptor stimulation-induced epigenetic changes and Foxp3 expression are independent and complementary events required for Treg cell development","volume":"37","author":"Ohkura","year":"2012","journal-title":"Immunity"},{"key":"R5-20250526","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1084\/jem.20030152","article-title":"Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-\u03b2 induction of transcription factor Foxp3","volume":"198","author":"Chen","year":"2003","journal-title":"J Exp Med"},{"key":"R6-20250526","first-page":"1079","article-title":"IL-10 induces the tyrosine phosphorylation of tyk2 and Jak1 and the differential assembly of STAT1 alpha and STAT3 complexes in human T cells and monocytes","volume":"155","author":"Finbloom","journal-title":"J Immunol Baltim Md"},{"key":"R7-20250526","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1084\/jem.170.6.2081","article-title":"Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones","volume":"170","author":"Fiorentino","year":"1989","journal-title":"J Exp Med"},{"key":"R8-20250526","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1084\/jem.174.4.915","article-title":"Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression","volume":"174","author":"de Waal Malefyt","year":"1991","journal-title":"J Exp Med"},{"key":"R9-20250526","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/nature09370","article-title":"Inhibition of follicular T-helper cells by CD8(+) regulatory T cells is essential for self tolerance","volume":"467","author":"Kim","year":"2010","journal-title":"Nature"},{"key":"R10-20250526","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/s41586-019-1467-x","article-title":"Opposing T cell responses in experimental autoimmune encephalomyelitis","volume":"572","author":"Saligrama","year":"2019","journal-title":"Nature"},{"key":"R11-20250526","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1172\/JCI84181","article-title":"NADPH oxidase deficiency underlies dysfunction of aged CD8+ Tregs","volume":"126","author":"Wen","year":"2016","journal-title":"J Clin Invest"},{"key":"R12-20250526","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1002\/art.34327","article-title":"Interleukin-21 modulates Th1 and Th17 responses in giant cell arteritis","volume":"64","author":"Terrier","year":"2012","journal-title":"Arthritis Rheum"},{"key":"R13-20250526","doi-asserted-by":"crossref","first-page":"e1332","DOI":"10.1002\/cti2.1332","article-title":"Improvement of Treg immune response after treatment with tocilizumab in giant cell arteritis","volume":"10","author":"Samson","year":"2021","journal-title":"Clin Transl Immunol"},{"key":"R14-20250526","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1136\/annrheumdis-2016-210070","article-title":"An expanded population of pathogenic regulatory T cells in giant cell arteritis is abrogated by IL-6 blockade therapy","volume":"76","author":"Miyabe","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"R15-20250526","doi-asserted-by":"crossref","first-page":"17003","DOI":"10.1074\/jbc.M801286200","article-title":"Foxp3 inhibits RORgammat-mediated IL-17A mRNA transcription through direct interaction with RORgammat","volume":"283","author":"Ichiyama","year":"2008","journal-title":"J Biol Chem"},{"key":"R16-20250526","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/nature06878","article-title":"TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function","volume":"453","author":"Zhou","year":"2008","journal-title":"Nature"},{"key":"R17-20250526","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1136\/annrheumdis-2021-220955","article-title":"Novel aspects of regulatory T cell dysfunction as a therapeutic target in giant cell arteritis","volume":"81","author":"Adriawan","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"R18-20250526","doi-asserted-by":"crossref","first-page":"136042","DOI":"10.1172\/JCI136042","article-title":"NOTCH-induced rerouting of endosomal trafficking disables regulatory T cells in vasculitis","volume":"131","author":"Jin","year":"2021","journal-title":"J Clin Invest"},{"key":"R19-20250526","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1002\/art.39037","article-title":"Th1 and Th17 cytokines drive inflammation in Takayasu arteritis","volume":"67","author":"Saadoun","year":"2015","journal-title":"Arthritis Rheumatol Hoboken NJ"},{"key":"R20-20250526","doi-asserted-by":"crossref","first-page":"768244","DOI":"10.3389\/fimmu.2021.768244","article-title":"Decreased absolute number of circulating regulatory T cells in patients with Takayasu's arteritis","volume":"12","author":"Jia","year":"2021","journal-title":"Front Immunol"},{"key":"R21-20250526","first-page":"48","article-title":"Contribution of Th2-like Treg cells to the pathogenesis of Takayasu's arteritis","volume":"38","author":"Gao","year":"2020","journal-title":"Clin Exp Rheumatol"},{"key":"R22-20250526","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1365-2567.2009.03213.x","article-title":"Patients with Wegener's granulomatosis demonstrate a relative deficiency and functional impairment of T-regulatory cells","volume":"130","author":"Morgan","year":"2010","journal-title":"Immunology"},{"key":"R23-20250526","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1002\/art.37959","article-title":"Patients with antineutrophil cytoplasmic antibody-associated vasculitis have defective Treg cell function exacerbated by the presence of a suppression-resistant effector cell population","volume":"65","author":"Free","year":"2013","journal-title":"Arthritis Rheum"},{"key":"R24-20250526","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.molimm.2019.11.010","article-title":"Reduced activated regulatory T cells and imbalance of Th17\/activated Treg cells marks renal involvement in ANCA-associated vasculitis","volume":"118","author":"Wang","year":"2020","journal-title":"Mol Immunol"},{"key":"R25-20250526","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.3389\/fimmu.2019.02170","article-title":"Increased miR-142-3p expression might explain reduced regulatory T cell function in granulomatosis with polyangiitis","volume":"10","author":"Dekkema","year":"2019","journal-title":"Front Immunol"},{"key":"R26-20250526","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1002\/eji.201646810","article-title":"Skewing toward Treg and Th2 responses is a characteristic feature of sustained remission in ANCA-positive granulomatosis with polyangiitis","volume":"47","author":"Szczeklik","year":"2017","journal-title":"Eur J Immunol"},{"key":"R27-20250526","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1681\/ASN.2020060834","article-title":"Anti-CD20 mAb-induced B cell apoptosis generates T cell regulation of experimental myeloperoxidase ANCA-associated vasculitis","volume":"32","author":"Gan","year":"2021","journal-title":"J Am Soc Nephrol JASN"},{"key":"R28-20250526","doi-asserted-by":"crossref","first-page":"3428","DOI":"10.1182\/blood-2003-07-2598","article-title":"CD4+CD25+ regulatory T-cell deficiency in patients with hepatitis C-mixed cryoglobulinemia vasculitis","volume":"103","author":"Boyer","year":"2004","journal-title":"Blood"},{"key":"R29-20250526","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1056\/NEJMoa1105143","article-title":"Regulatory T-cell responses to low-dose interleukin-2 in HCV-induced vasculitis","volume":"365","author":"Saadoun","year":"2011","journal-title":"N Engl J Med"},{"key":"R30-20250526","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1053\/j.gastro.2017.03.006","article-title":"Efficacy and safety of sofosbuvir plus daclatasvir for treatment of HCV-associated cryoglobulinemia vasculitis","volume":"153","author":"Saadoun","year":"2017","journal-title":"Gastroenterology"},{"key":"R31-20250526","doi-asserted-by":"crossref","first-page":"5334","DOI":"10.1182\/blood-2007-11-122713","article-title":"Restoration of peripheral immune homeostasis after rituximab in mixed cryoglobulinemia vasculitis","volume":"111","author":"Saadoun","year":"2008","journal-title":"Blood"},{"key":"R32-20250526","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.jaci.2011.05.029","article-title":"Critical role of IL-21 in modulating TH17 and regulatory T cells in Beh\u00e7et disease","volume":"128","author":"Geri","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"R33-20250526","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1007\/s00296-013-2835-8","article-title":"Regulatory T cells in Beh\u00e7et's disease: is there a correlation with disease activity? Does regulatory T cell type matter?","volume":"33","author":"G\u00fcnd\u00fcz","year":"2013","journal-title":"Rheumatol Int"},{"key":"R34-20250526","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/nature05969","article-title":"Essential autocrine regulation by IL-21 in the generation of inflammatory T cells","volume":"448","author":"Nurieva","year":"2007","journal-title":"Nature"},{"key":"R35-20250526","doi-asserted-by":"crossref","first-page":"5375","DOI":"10.1182\/blood-2009-05-221135","article-title":"IL-21 blockade reduces graft-versus-host disease mortality by supporting inducible T regulatory cell generation","volume":"114","author":"Bucher","year":"2009","journal-title":"Blood"},{"key":"R36-20250526","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1093\/rheumatology\/keab253","article-title":"Regulatory T cell\/Th17 balance in the pathogenesis of paediatric Beh\u00e7et disease","volume":"61","author":"Filleron","year":"2021","journal-title":"Rheumatol Oxf Engl"},{"key":"R37-20250526","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1002\/jcp.27207","article-title":"Disturbed Th17\/Treg balance, cytokines, and miRNAs in peripheral blood of patients with Behcet's disease","volume":"234","author":"Ahmadi","year":"2019","journal-title":"J Cell Physiol"},{"key":"R38-20250526","doi-asserted-by":"crossref","first-page":"9","DOI":"10.5152\/eurjrheum.2017.17068","article-title":"Long-term efficacy of infliximab treatment and the predictors of treatment outcomes in patients with refractory uveitis associated with Beh\u00e7et's disease","volume":"5","author":"Ueda","year":"2018","journal-title":"Eur J Rheumatol"},{"key":"R39-20250526","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/39614","article-title":"A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis","volume":"389","author":"Groux","year":"1997","journal-title":"Nature"},{"key":"R40-20250526","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.immuni.2011.03.018","article-title":"Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation","volume":"34","author":"Chaudhry","year":"2011","journal-title":"Immunity"},{"key":"R41-20250526","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1073\/pnas.89.5.1890","article-title":"Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes","volume":"89","author":"Rousset","year":"1992","journal-title":"Proc Natl Acad Sci"},{"key":"R42-20250526","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1006\/cyto.1998.0371","article-title":"Preincubation of human resting T cell clones with interleukin 10 strongly enhances their ability to produce cytokines after stimulation","volume":"10","author":"Lelievre","year":"1998","journal-title":"Cytokine"},{"key":"R43-20250526","doi-asserted-by":"crossref","first-page":"3188","DOI":"10.4049\/jimmunol.160.7.3188","article-title":"Inhibitory and stimulatory effects of IL-10 on human CD8+ T Cells","volume":"160","author":"Groux","year":"1998","journal-title":"J Immunol"},{"key":"R44-20250526","first-page":"2783","article-title":"Proinflammatory effects of IL-10 during human endotoxemia","volume":"165","author":"Lauw","journal-title":"J Immunol Baltim Md"},{"key":"R45-20250526","doi-asserted-by":"crossref","first-page":"6405","DOI":"10.1038\/s41598-020-63042-3","article-title":"Immunomodulatory role of interleukin-33 in large vessel vasculitis","volume":"10","author":"Desbois","year":"2020","journal-title":"Sci Rep"},{"key":"R46-20250526","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/s41598-018-36825-y","article-title":"Serum levels of fibroblast growth factor-2 distinguish Takayasu arteritis from giant cell arteritis independent of age at diagnosis","volume":"9","author":"Fukui","year":"2019","journal-title":"Sci Rep"},{"key":"R47-20250526","article-title":"Increased salivary cytokines and nitric oxide levels in Beh\u00e7et's disease: interleukin-32, a novel player in disease prognosis","author":"Hadjimi","year":"2022","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"R48-20250526","doi-asserted-by":"crossref","first-page":"724900","DOI":"10.3389\/fimmu.2021.724900","article-title":"Saliva and serum cytokine profiles during oral ulceration in Beh\u00e7et's disease","volume":"12","author":"Novak","year":"2021","journal-title":"Front Immunol"},{"key":"R49-20250526","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/ng.625","article-title":"Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Beh\u00e7et's disease","volume":"42","author":"Remmers","year":"2010","journal-title":"Nat Genet"},{"key":"R50-20250526","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.autrev.2014.12.009","article-title":"IFN-\u03b1 induces IL-10 production and tilt the balance between Th1 and Th17 in Beh\u00e7et disease","volume":"14","author":"Touzot","year":"2015","journal-title":"Autoimmun Rev"},{"key":"R51-20250526","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1007\/s00296-019-04364-y","article-title":"Cytokine profiling in anti neutrophil cytoplasmic antibody-associated vasculitis: a cross-sectional cohort study","volume":"39","author":"Hoffmann","year":"2019","journal-title":"Rheumatol Int"},{"key":"R52-20250526","doi-asserted-by":"crossref","first-page":"553","DOI":"10.3109\/08820139.2015.1043670","article-title":"Meta-analysis of associations between interleukin-10 polymorphisms and susceptibility to vasculitis","volume":"44","author":"Jung","year":"2015","journal-title":"Immunol Invest"},{"key":"R53-20250526","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.jhep.2004.08.011","article-title":"Predominance of type 1 (Th1) cytokine production in the liver of patients with HCV-associated mixed cryoglobulinemia vasculitis","volume":"41","author":"Saadoun","year":"2004","journal-title":"J Hepatol"},{"key":"R54-20250526","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1007\/s12072-011-9268-9","article-title":"Is interleukin-8 an additional to histopathological changes diagnostic marker in HCV-infected patients with cryoglobulinemia?","volume":"5","author":"Cielecka-Kuszyk","year":"2011","journal-title":"Hepatol Int"},{"key":"R55-20250526","first-page":"5492","article-title":"A randomized, controlled trial of IL-10 in humans. Inhibition of inflammatory cytokine production and immune responses","volume":"154","author":"Chernoff","journal-title":"J Immunol Baltim Md"},{"key":"R56-20250526","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1136\/annrheumdis-2018-214229","article-title":"Immunological and clinical effects of low-dose interleukin-2 across 11 autoimmune diseases in a single, open clinical trial","volume":"78","author":"Rosenzwajg","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"R57-20250526","doi-asserted-by":"crossref","first-page":"103156","DOI":"10.1016\/j.autrev.2022.103156","article-title":"Short-term and low-dose IL-2 therapy increases the reduced Treg cells in patients with microscopic polyangiitis","volume":"21","author":"Wu","year":"2022","journal-title":"Autoimmun Rev"},{"key":"R58-20250526","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.clim.2014.03.016","article-title":"Therapy of type 1 diabetes with CD4(+)CD25(high)CD127-regulatory T cells prolongs survival of pancreatic islets - results of one year follow-up","volume":"153","author":"Marek-Trzonkowska","year":"2014","journal-title":"Clin Immunol Orlando Fla"},{"key":"R59-20250526","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1002\/eji.200839196","article-title":"Natural Treg cells spontaneously differentiate into pathogenic helper cells in lymphopenic conditions","volume":"39","author":"Duarte","year":"2009","journal-title":"Eur J Immunol"},{"key":"R60-20250526","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1172\/JCI82771","article-title":"Alloantigen-specific regulatory T cells generated with a chimeric antigen receptor","volume":"126","author":"MacDonald","year":"2016","journal-title":"J Clin Invest"},{"key":"R61-20250526","doi-asserted-by":"crossref","first-page":"102289","DOI":"10.1016\/j.jaut.2019.05.017","article-title":"Regulatory T cells engineered with a novel insulin-specific chimeric antigen receptor as a candidate immunotherapy for type 1 diabetes","volume":"103","author":"Tenspolde","year":"2019","journal-title":"J Autoimmun"},{"key":"R62-20250526","first-page":"16","article-title":"CD8+ T cells expressing an HLA-DR1 chimeric antigen receptor target autoimmune CD4+ T cells in an antigen-specific manner and inhibit the development of autoimmune arthritis","volume":"208","author":"Whittington","journal-title":"J Immunol Baltim Md"},{"key":"R63-20250526","doi-asserted-by":"crossref","first-page":"44179","DOI":"10.18632\/oncotarget.6175","article-title":"Therapeutic potential of CAR-T cell-derived exosomes: a cell-free modality for targeted cancer therapy","volume":"6","author":"Tang","year":"2015","journal-title":"Oncotarget"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0000000000000915","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T21:17:15Z","timestamp":1748294235000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0000000000000915"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,20]]},"references-count":63,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0000000000000915","relation":{},"ISSN":["1040-8711","1531-6963"],"issn-type":[{"value":"1040-8711","type":"print"},{"value":"1531-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,20]]}}}